Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA grants orphan drug status to recombinant Pharming product

March 26, 1999

Inhibitors of MCP-1 disclosed by Zeneca for inflammation

March 25, 1999

Amgen patents novel hydroxamic acid-based MMP inhibitors

March 22, 1999

Pfizer discloses selective hydroxamic acid-based MMP-13 inhibitors

March 19, 1999

FDA approves Prosorba Column for use in rheumatoid arthritis

March 18, 1999

Celgene describes new series for reducing TNF-alpha levels

March 18, 1999

Peripheral cannabinoid receptor ligands in development at Japan Tobacco

March 16, 1999

Roberts acquires Lodine rights in the U.K. and Ireland

March 12, 1999

Vertex initiates phase I clinical trial with VX-745

March 11, 1999

Cypress Bioscience and Fresenius sign definitive agreement for Prosorba Column

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...